Medco Research
Executive Summary
Acquires Robins' antihypertensive Tenathan (bethanidine). Approved in 1981 for the treatment of hypertension, Tenathan has never been marketed in the U.S. Medco says it "intends to test bethandidine in the prevention and treatment of ventricular fibrillation," with clinical studies beginning "in the near future." Robins retains right to manufacture and market the product under a royalty agreement.